EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

BAMBI integrates biostatistical and artificial intelligence methods to improve RNA biomarker discovery

Peng Zhou, Zixiu Li, Feifan Liu, Euijin Kwon, Tien-Chan Hsieh, Shangyuan Ye, Shobha Vasudevan, Jung Ae Lee, Khanh-Van Tran, Chan Zhou iD

Briefings in Bioinformatics · 04.03.2025 · 26 (2)

DOI: 10.1093/bib/bbaf073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Briefings in Bioinformatics, erschienen am 04.03.2025. Verfasst von Peng Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, MA 01655, United States. Hauptthemen laut MEDLINE: Artificial Intelligence, Biomarkers, Tumor, Computational Biology, Software. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA biomarkers enable early and precise disease diagnosis, monitoring, and prognosis, facilitating personalized medicine and targeted therapeutic strategies. However, identification of RNA biomarkers is hindered by the challenge of analyzing relatively small yet high-dimensional transcriptomics datasets, typically comprising fewer than 1000 biospecimens but encompassing hundreds of thousands of RNAs, especially noncoding RNAs. This complexity leads to several limitations in existing methods, such as poor reproducibility on independent datasets, inability to directly process omics data, and difficulty in identifying noncoding RNAs as biomarkers. Additionally, these methods often yield results that lack biological interpretation and clinical utility. To overcome these challenges, we present BAMBI (Biostatistical and Artificial-intelligence Methods for Biomarker Identification), a computational tool integrating biostatistical approaches and machine-learning algorithms. By initially reducing high dimensionality through biologically informed statistical methods followed by machine learning–based feature selection, BAMBI significantly enhances the accuracy and clinical utility of identified RNA biomarkers and also includes noncoding RNA biomarkers that existing methods may overlook. BAMBI outperformed existing methods on both real and simulated datasets by identifying individual and panel biomarkers with fewer RNAs while still ensuring superior prediction accuracy. BAMBI was benchmarked on multiple transcriptomics datasets across diseases, including breast cancer, psoriasis, and leukemia. The prognostic biomarkers for acute myeloid leukemia discovered by BAMBI showed significant correlations with patient survival rates in an independent cohort, highlighting its potential for enhancing clinical outcomes. The software is available on GitHub (https://github.com/CZhouLab/BAMBI).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceBiomarkers, TumorComputational BiologySoftwareBiostatisticsRNAHumansAlgorithmsMachine LearningBiomarkers

Stichwörter der Autor:innen

biomarkerdiagnosis and prognosishigh-dimensionality reductionmachine learningnoncoding RNAstatistics

Substanzen

Biomarkers, TumorRNABiomarkers

Autor:innen und Institutionen

  • Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, MA 01655, United States.
  • Program in Bioinformatics and Integrative Biology, University of Massachusetts Chan Medical School, Worcester, MA 01655, United States.
  • Division of Hematology-Oncology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01655, United States.
  • Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health and Science University, 2720 S Moody Ave, Portland, OR 97201, United States.
  • Brown RNA Center, Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI 02903, United States.
  • Division of Cardiology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01655, United States.

ORCID-Profile: Chan Zhou

Zitieren

APA

Zhou, P., Li, Z., Liu, F., Kwon, E., Hsieh, T. C., Ye, S., Vasudevan, S., Lee, J. A., Tran, K. V., & Zhou, C. (2025). BAMBI integrates biostatistical and artificial intelligence methods to improve RNA biomarker discovery. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbaf073

Vancouver

Zhou P, Li Z, Liu F, Kwon E, Hsieh TC, Ye S, et al. BAMBI integrates biostatistical and artificial intelligence methods to improve RNA biomarker discovery. Briefings in Bioinformatics. 2025. doi:10.1093/bib/bbaf073

BibTeX
@article{Zhou2025,
  author = {Zhou, Peng and Li, Zixiu and Liu, Feifan and Kwon, Euijin and Hsieh, Tien-Chan and Ye, Shangyuan and Vasudevan, Shobha and Lee, Jung Ae and Tran, Khanh-Van and Zhou, Chan},
  title = {BAMBI integrates biostatistical and artificial intelligence methods to improve RNA biomarker discovery},
  journal = {Briefings in Bioinformatics},
  year = {2025},
  doi = {10.1093/bib/bbaf073}
}
Kostenlos starten →